The most frequent polymorphism in CDKN2A, a substitution in the 3′ UTR of a cytosine for a guanine base at cDNA nucleotide 500 (numbered from the p16INK4a initiation codon, rs11515), is associated with different cancer types. Here, CDKN2A is linked to cancer.